|
Name |
(5Z)-5-[(3,4-dihydroxy-5-methoxy-phenyl)methylene]-4-hydroxy-3-(4-hydroxyphenyl)furan-2-one
|
| Molecular Formula | C18H14O7 | |
| IUPAC Name* |
(5Z)-5-[(3,4-dihydroxy-5-methoxyphenyl)methylidene]-4-hydroxy-3-(4-hydroxyphenyl)furan-2-one
|
|
| SMILES |
COC1=CC(=CC(=C1O)O)/C=C\2/C(=C(C(=O)O2)C3=CC=C(C=C3)O)O
|
|
| InChI |
InChI=1S/C18H14O7/c1-24-13-7-9(6-12(20)16(13)21)8-14-17(22)15(18(23)25-14)10-2-4-11(19)5-3-10/h2-8,19-22H,1H3/b14-8-
|
|
| InChIKey |
MYJVNAXQWDAVRD-ZSOIEALJSA-N
|
|
| Synonyms |
CHEMBL4175853; (5Z)-5-[(3,4-dihydroxy-5-methoxy-phenyl)methylene]-4-hydroxy-3-(4-hydroxyphenyl)furan-2-one
|
|
| CAS | NA | |
| PubChem CID | 134815743 | |
| ChEMBL ID | CHEMBL4175853 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 342.3 | ALogp: | 2.2 |
| HBD: | 4 | HBA: | 7 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 116.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 25 | QED Weighted: | 0.498 |
| Caco-2 Permeability: | -5.055 | MDCK Permeability: | 0.00001870 |
| Pgp-inhibitor: | 0.012 | Pgp-substrate: | 0.017 |
| Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.989 |
| 30% Bioavailability (F30%): | 0.154 |
| Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 95.14% |
| Volume Distribution (VD): | 0.502 | Fu: | 5.93% |
| CYP1A2-inhibitor: | 0.344 | CYP1A2-substrate: | 0.277 |
| CYP2C19-inhibitor: | 0.117 | CYP2C19-substrate: | 0.063 |
| CYP2C9-inhibitor: | 0.533 | CYP2C9-substrate: | 0.845 |
| CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.238 |
| CYP3A4-inhibitor: | 0.663 | CYP3A4-substrate: | 0.289 |
| Clearance (CL): | 8.323 | Half-life (T1/2): | 0.833 |
| hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.191 |
| Drug-inuced Liver Injury (DILI): | 0.694 | AMES Toxicity: | 0.056 |
| Rat Oral Acute Toxicity: | 0.524 | Maximum Recommended Daily Dose: | 0.611 |
| Skin Sensitization: | 0.614 | Carcinogencity: | 0.128 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.442 |
| Respiratory Toxicity: | 0.227 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005411 | ![]() |
0.808 | D0K8KX | ![]() |
0.372 | ||
| ENC005410 | ![]() |
0.766 | D04AIT | ![]() |
0.366 | ||
| ENC003373 | ![]() |
0.705 | D07MGA | ![]() |
0.354 | ||
| ENC002800 | ![]() |
0.598 | D06GCK | ![]() |
0.353 | ||
| ENC001573 | ![]() |
0.494 | D0AZ8C | ![]() |
0.315 | ||
| ENC001548 | ![]() |
0.477 | D0R6BI | ![]() |
0.306 | ||
| ENC005039 | ![]() |
0.469 | D06TJJ | ![]() |
0.306 | ||
| ENC001771 | ![]() |
0.455 | D04XEG | ![]() |
0.287 | ||
| ENC002756 | ![]() |
0.453 | D0E9CD | ![]() |
0.286 | ||
| ENC002757 | ![]() |
0.448 | D0Y7PG | ![]() |
0.281 | ||